Hyperinsulinism in an individual with an <scp><i>EP300</i></scp> variant of <scp>Rubinstein‐Taybi</scp> syndrome
K. Taylor Wild(Children's Hospital of Philadelphia), Elaine H. Zackai(Children's Hospital of Philadelphia), Sarah E. Sheppard(Children's Hospital of Philadelphia), Diva D. De León(Children's Hospital of Philadelphia), Tomoki Nomakuchi(Children's Hospital of Philadelphia), Karla F. Leavens(Children's Hospital of Philadelphia)
Cited by 5
Related Papers
Further Delineation of Deletion 1p36 Syndrome in 60 Patients: A Recognizable Phenotype and Common Cause of Developmental Delay and Mental Retardation
|PEDIATRICS|2008|310
Molecular and Clinical Analyses of Greig Cephalopolysyndactyly and Pallister-Hall Syndromes: Robust Phenotype Prediction from the Type and Position of GLI3 Mutations
|The American Journal of Human Genetics|2005|277
<i>GRIN2B</i> encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects
|Journal of Medical Genetics|2017|254
CC2D2A Is Mutated in Joubert Syndrome and Interacts with the Ciliopathy-Associated Basal Body Protein CEP290
|The American Journal of Human Genetics|2008|230
Mutations in PDGFRB Cause Autosomal-Dominant Infantile Myofibromatosis
|The American Journal of Human Genetics|2013|206